Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Graham Russell, Emeritus Professor of Musculoskeletal Pharmacology at NDORMS, has received the prestigious Gideon A. Rodan Excellence in Mentorship Award from the American Society for Bone and Mineral Research (ASBMR).

We are proud to congratulate Professor Graham Russell, Emeritus Professor of Musculoskeletal Pharmacology at NDORMS, on receiving the prestigious Gideon A. Rodan Excellence in Mentorship Award from the American Society for Bone and Mineral Research (ASBMR), at their annual meeting in Houston, Texas this September.

This award is given in recognition of outstanding support provided by a senior scientist who has helped promote the independent careers of young investigators in bone and mineral metabolism; it is certain that Prof Russell has and continues to encourage the careers of a vast number of successful musculoskeletal researchers.

This is the first time this award has been presented to a researcher from outside the US and is an excellent testimony to Professor Russell's achievements at NDORMS and within the field as a whole.

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.